Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR-T cells....
HanchorBio Presents Preclinical Data on HCB301 at SITC 2025
HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling in preclinical solid tumor models. TAIPEI, SHANGHAI, and SAN FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that the...
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and development of bispecific antibodies for the treatment of...
SingHealth Duke-NUS Launches Two New Global Health Centres to Advance Allied Health and Pharmacy Practices in Asia
The Centre for Global Allied Health and Centre for Global Pharmacy will advance global health collaboration and capacity building, with a focus on strengthening allied health and pharmacy practices across Asia. Both centres build on a legacy of more than 120 global health projects led by SingHealth and Duke-NUS partners, addressing urgent...
NEC Drives the Future of Smart Living By Elevating Health, Cybersecurity, and Disaster Resilience at Thailand Smart City Expo 2025
BANGKOK, Nov. 5, 2025 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. reaffirms its commitment to creating social value for Thailand by empowering cities, people, and businesses with advanced technology. Guided by NEC's global purpose to "create the social values of safety, security, fairness, and efficiency," the company presents breakthrough innovations aligned with four...
Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results
MILPITAS, Calif., Nov. 5, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the third quarter of 2025. Third Quarter 2025 Financial and Operating Highlights: Revenue reached US$75.8 million, representing 78.5% year-over-year growth, meeting the upper end of our guidance range. GAAP and adjusted operating result was...
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek®...
-Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction; safe and well tolerated with only mild-to-moderate gastrointestinal (GI) adverse events (AEs) across all multiple ascending dose (MAD) cohorts. -Phase Ib study data of ASC30 subcutaneous (SQ) injection showed that observed half-life reached 46 days for the treatment formulation...
Mölnlycke® establishes first wound care manufacturing site in China
CHANGSHU, China and GOTHENBURG, Sweden, Nov. 5, 2025 /PRNewswire/ -- Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke's growth journey and the beginning of localised manufacturing...
Angel Yeast starts Operating New 11,000-Ton Yeast Protein Production Line to Meet Global Demand for Sustainable Nutrition
YICHANG, China, Nov. 5, 2025 /PRNewswire/ -- Angel Yeast Co., Ltd. (SH600298) has officially started operations at its next-generation yeast protein production line at the Baiyang Biotechnology Park in Yichang, Hubei. The facility has an annual production capacity of 11,000 tons of high-purity yeast protein with a protein content exceeding 80%. This marks...
Health In Tech Announces New Davos 2026 Panel: “First Ladies: Backing Women Who Build” Featuring Cherie Blair CBE, KC
STUART, Fla., Nov. 5, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced an expansion of its agenda for the Independent InsurTech Summit to be held during World Economic Forum Week 2026 in Davos, Switzerland. Following the previously announced CEO panel, "AI...
